Governance
The governance consists of the following :
- The coordinating institution (Université de Montpellier)
- A steering committee
- A scientific committee
- An executive team
It operates at two levels, Strategic and Scientific/Operational :
Strategic
The Steering Committee’s purpose is to define the strategic orientations and the objectives, and to supervise the infrastructure’s
activities.
- Christian Jorgensen, coordinateur, UM
- Jacques Mercier, UM director
- Louis Casteilla, STROMALab
- Olivier Detante, GIN, CHU of Grenoble
- Hélène Rouard, EFS
- Anaïck Moisan, EFS
- Philipe Saas, EFS
- Christophe Martinaud, CTSA
The Scientific Advisory Board consists of international experts in the fields of regulatory issues in cell therapy, mesenchymal stem cell,
and security and QC in GMP production.
- Pierre Charbord (Emeritus Director Inserm U972)
- Jérôme Guicheux (DR Inserm, Nantes, France)
- Florence Sabatier (PU-PH, Marseille, France)
- Jacques Galipeau (MD, Madison, USA)
Scientific and operational
The Innovation Scientific Committee issues practical recommendations to the Steering committee on the scientific orientations. It suggests
novel research strategies and evaluates external projects.
- Christian Jorgensen, coordinateur, UM
- Danièle Noël, U1183
- Pascale Louis-Plence, U1183
- Louis Casteilla, STROMALab
- Olivier Detante, GIN, CHU of Grenoble
- Hélène Rouard, EFS
- Karin Tarte, EFS
- Christophe Martinaud, CTSA
The Executive team's purpose is to coordinate ECELLFRANCE and to drive the changes and implementations decided by the steering
committee.
- Christian Jorgensen, coordinateur, UM
- Séverine Kremer, project manager, UM
- Christophe Martinaud, CTSA
- Anaïck Moisan, EFS
- Louis Casteilla, STROMALab
- Pascale Louis-Plence, UM
- Sandrine Fleury, EFS
- Hélène Rouard, EFS